We are live on
!
Find out more
EHWM
Eads & Heald Wealth Management Portfolio holdings
AUM
$201M
1-Year Est. Return
21.29%
This Fund
S&P 500
This Quarter
Est. Return
+1.23%
1 Year Est. Return
+21.29%
3 Year Est. Return
+70.18%
5 Year Est. Return
+104.01%
10 Year Est. Return
+364.64%
AUM
$201M
AUM Growth
-$5.98M
(-2.9%)
Cap. Flow
-$4.09M
Cap. Flow
% of AUM
-2.04%
Top 10 Holdings %
Top 10 Hldgs %
18.68%
Holding
143
New
2
Increased
41
Reduced
92
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$858K |
| 2 |
Hubbell
HUBB
|
+$419K |
| 3 |
Eli Lilly
LLY
|
+$315K |
| 4 |
Waters Corp
WAT
|
+$265K |
| 5 |
Paychex
PAYX
|
+$255K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$906K |
| 2 |
Caterpillar
CAT
|
+$873K |
| 3 |
NVIDIA
NVDA
|
+$533K |
| 4 |
Amphenol
APH
|
+$467K |
| 5 |
Starbucks
SBUX
|
+$417K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.67% |
| 2 | Industrials | 17.55% |
| 3 | Healthcare | 14.68% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Consumer Staples | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
APA Corp
APA
$12.8B
| $357K | 0.18% |
8,406
+100
| +1% | +$3.02K |
|
127
Constellation Brands
STZ
$22.6B
| $345K | 0.17% |
2,301
+645
| +39% | +$99.6K |
|
128
Salesforce
CRM
$133B
| $321K | 0.16% |
1,722
-687
| -29% | -$142K |
|
129
Quest Diagnostics
DGX
$23.2B
| $304K | 0.15% |
1,549
-4
| -0.3% | -$777 |
|
130
Pfizer
PFE
$141B
| $303K | 0.15% |
10,806
+280
| +3% | +$7.46K |
|
131
Mondelez International
MDLZ
$78.1B
| $280K | 0.14% |
4,860
-960
| -16% | -$55.6K |
|
132
Crown Holdings
CCK
$13B
| $279K | 0.14% |
2,781
-155
| -5% | -$16.6K |
|
133
BP
BP
$112B
| $278K | 0.14% |
5,925
+165
| +3% | +$6.46K |
|
134
AT&T
T
$160B
| $271K | 0.14% |
9,362
+50
| +0.5% | +$1.34K |
|
135
Graco
GGG
$12.3B
| $264K | 0.13% |
3,120
-70
| -2% | -$6.2K |
|
136
Duke Energy
DUK
$99.7B
| $261K | 0.13% |
1,994
-65
| -3% | -$8.13K |
|
137
Toll Brothers
TOL
$13.9B
| $247K | 0.12% |
1,812
-154
| -8% | -$22.6K |
|
|
138
Paychex
PAYX
$39.4B
| $237K | 0.12% |
+2,574
| New | +$255K |
|
139
Lincoln National
LNC
$7.97B
| $234K | 0.12% |
6,598
| – | – |
|
140
GSK
GSK
$102B
| $219K | 0.11% |
3,971
-320
| -7% | -$17.3K |
|
141
Agilent Technologies
A
$37.7B
| – | – |
-1,549
| Closed | -$211K |
|
142
Bank of America
BAC
$432B
| – | – |
-3,861
| Closed | -$212K |
|
143
Citigroup
C
$222B
| – | – |
-2,796
| Closed | -$326K |
|
Similar funds
LI
FFL
SWIA
FCM
FIA
SA
FFC
RM
Eads & Heald Wealth Management's Q1 2026 Portfolio in Review
As of Q1 2026, Eads & Heald Wealth Management held 143 positions worth $201M, down 2.9% from $207M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.5%. Eads & Heald Wealth Management opened 2 new positions and exited 3, leaving the 143-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Industrials and Healthcare.
- Eads & Heald Wealth Management's largest Q1 2026 buy was Gilead Sciences: 6,128 shares worth $854K.
- Eads & Heald Wealth Management added most to Hubbell in Q1 2026, an estimated $419K increase.
- Eads & Heald Wealth Management's biggest Q1 2026 reduction was Lam Research, cutting an estimated $906K.
- Eads & Heald Wealth Management fully exited Citigroup in Q1 2026, selling an estimated $326K.
- Eads & Heald Wealth Management's ten largest holdings make up 19% of its $201M portfolio in Q1 2026.
- Eads & Heald Wealth Management opened 2 new positions and closed 3 in Q1 2026.
- Eads & Heald Wealth Management's portfolio value fell 2.9% quarter-over-quarter to $201M.
Based on Eads & Heald Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.